BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, focusing on diverse patient populations, including individuals with intellectual and developmental disabilities and those in need of rehabilitation support. The company prioritizes personalized, high-quality care, facilitated by a dedicated and skilled workforce that significantly improves patient outcomes and quality of life. With robust investments in innovative technologies and a strong commitment to value-based care, BrightSpring is well-positioned to capitalize on growth opportunities within the dynamic healthcare landscape, highlighting its potential for sustainable, long-term success.
| Revenue (TTM) | $13.65B |
| Gross Profit (TTM) | $1.66B |
| EBITDA | $552.97M |
| Operating Margin | 3.36% |
| Return on Equity | 9.23% |
| Return on Assets | 4.07% |
| Revenue/Share (TTM) | $67.06 |
| Book Value | $9.66 |
| Price-to-Book | 7.14 |
| Price-to-Sales (TTM) | 1.04 |
| EV/Revenue | 1.168 |
| EV/EBITDA | 30.23 |
| Quarterly Earnings Growth (YoY) | 359.80% |
| Quarterly Revenue Growth (YoY) | 25.60% |
| Shares Outstanding | $196.26M |
| Float | $176.67M |
| % Insiders | 3.16% |
| % Institutions | 102.34% |
Volatility is currently expanding
BrightSpring heads into Q2 earnings with pharmacy and provider momentum, rising estimates and margin gains despite IRA and generic-conversion pressure.
BrightSpring Health Services, Inc. (BTSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LOUISVILLE, Ky., July 08, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2026 financial results on Friday, July 31, 2026, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day.
Does BrightSpring Health Services, Inc. (BTSG) have what it takes to be a top stock pick for momentum investors? Let's find out.
BTSG's specialty, infusion and provider services momentum support growth, but IRA pressures and integration risks may weigh on margins.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
If you are looking for stocks that are well positioned to maintain their recent uptrend, BrightSpring Health Services, Inc. (BTSG) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Let's take a look at four stocks, BTSG, KNSA, ATI and VMI, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.
BrightSpring, Dycom, StoneX and Orion stand out as buy-worthy stocks, backed by rising cash flows and upward earnings estimate revisions.
Here is how BrightSpring Health Services, Inc. (BTSG) and Bioventus (BVS) have performed compared to their sector so far this year.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BTSG and any ticker you trade — then tracks every position and per-strategy win rate.
